PATENT CLAIM ANALYSIS

Application Number: 15778785
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["549", "359000"]

Abstract:
The present disclosure discloses a modified compound of andrographolide, and particularly discloses a compound shown in formula (I) and (II) or a pharmaceutically acceptable salt thereof.

Claim (Index 7):
The compound, pharmaceutically acceptable salt or tautomer thereof according to  claim 1 , wherein R 1  and R 4  are selected from H, COOH, or are selected from the group consisting of NH 2 , C 1-4  alkyl, C 1-4  heteroalkyl, azetidinyl, pyrrolidinyl, tetrahydropyranyl, piperidinyl, cyclohexyl, phenyl, pyridinyl, pyridine-2(1H)-keto, pyrimidyl, pyrazolyl, thiazolyl, benzothiazolyl, imidazo[1,2-b]pyridazinyl, isoxazolyl and thienyl, which is optionally substituted with 1, 2 or 3 R;\n specifically, R 1  and R 4  are selected from H, COOH, or are selected from the group consisting of NH 2 , which is optionally substituted with 1, 2 or 3 R;\n more specifically, R 1  and R 4  are selected from the group consisting of

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.28
- Patent Class: 549.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15910571', '13058227', '15575037', '11727927', '15517951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733063785538027
- 35 USC 102 Novelty (BERT): 0.536227780673518
- Combined Prediction Score: 0.7495985187657742
- Mean Citation Score: 352.99469000000005
- Max Citation Score: 361.08292
- Similarity Product: 263.53894972773315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test